NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green
Claire Egloff-Juras,1,2 Lina Bezdetnaya,1,3 Gilles Dolivet,1,3 Henri-Pierre Lassalle1,3 1Université de Lorraine, CNRS, CRAN, Nancy F-54000, France; 2Université de Lorraine, CHRU-Nancy, Institut de Cancérologie de Lorraine, Nancy F-54000, France; 3Institut de Cancérologie de L...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/821a3d36bb0e44a999b4eed4f3ce7828 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:821a3d36bb0e44a999b4eed4f3ce7828 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:821a3d36bb0e44a999b4eed4f3ce78282021-12-02T04:40:50ZNIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green1178-2013https://doaj.org/article/821a3d36bb0e44a999b4eed4f3ce78282019-09-01T00:00:00Zhttps://www.dovepress.com/nir-fluorescence-guided-tumor-surgery-new-strategies-for-the-use-of-in-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Claire Egloff-Juras,1,2 Lina Bezdetnaya,1,3 Gilles Dolivet,1,3 Henri-Pierre Lassalle1,3 1Université de Lorraine, CNRS, CRAN, Nancy F-54000, France; 2Université de Lorraine, CHRU-Nancy, Institut de Cancérologie de Lorraine, Nancy F-54000, France; 3Institut de Cancérologie de Lorraine, Nancy F-54000, FranceCorrespondence: Claire Egloff-JurasFaculté d’Odontologie de Lorraine, Université de Lorraine, 7 Avenue de la Forêt de Haye, Vandoeuvre-lès-Nancy, Nancy 54500, FranceTel +33 37 274 6760Email claire.juras@univ-lorraine.frAbstract: Surgery is the frontline treatment for a large number of cancers. The objective of these excisional surgeries is the complete removal of the primary tumor with sufficient safety margins. Removal of the entire tumor is essential to improve the chances of a full recovery. To help surgeons achieve this objective, near-infrared fluorescence-guided surgical techniques are of great interest. The concomitant use of fluorescence and indocyanine green (ICG) has proved effective in the identification and characterization of tumors. Moreover, ICG is authorized by the Food and Drug Administration and the European Medicines Agency and is therefore the subject of a large number of studies. ICG is one of the most commonly used fluorophores in near-infrared fluorescence-guided techniques. However, it also has some disadvantages, such as limited photostability, a moderate fluorescence quantum yield, a high plasma protein binding rate, and undesired aggregation in aqueous solution. In addition, ICG does not specifically target tumor cells. One way to exploit the capabilities of ICG while offsetting these drawbacks is to develop high-performance near-infrared nanocomplexes formulated with ICG (with high selectivity for tumors, high tumor-to-background ratios, and minimal toxicity). In this review article, we focus on recent developments in ICG complexation strategies to improve near-infrared fluorescence-guided tumor surgery. We describe targeted and nontargeted ICG nanoparticle models and ICG complexation with targeting agents.Keywords: near-infrared fluorescence-guided surgery, indocyanine green, nanoparticle, targeted nanoparticle, ICG complexationEgloff-Juras CBezdetnaya LDolivet GLassalle HPDove Medical PressarticleNear-infrared fluorescence-guided surgeryindocyanine greennanoparticletargeted nanoparticleICG complexationMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7823-7838 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Near-infrared fluorescence-guided surgery indocyanine green nanoparticle targeted nanoparticle ICG complexation Medicine (General) R5-920 |
spellingShingle |
Near-infrared fluorescence-guided surgery indocyanine green nanoparticle targeted nanoparticle ICG complexation Medicine (General) R5-920 Egloff-Juras C Bezdetnaya L Dolivet G Lassalle HP NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green |
description |
Claire Egloff-Juras,1,2 Lina Bezdetnaya,1,3 Gilles Dolivet,1,3 Henri-Pierre Lassalle1,3 1Université de Lorraine, CNRS, CRAN, Nancy F-54000, France; 2Université de Lorraine, CHRU-Nancy, Institut de Cancérologie de Lorraine, Nancy F-54000, France; 3Institut de Cancérologie de Lorraine, Nancy F-54000, FranceCorrespondence: Claire Egloff-JurasFaculté d’Odontologie de Lorraine, Université de Lorraine, 7 Avenue de la Forêt de Haye, Vandoeuvre-lès-Nancy, Nancy 54500, FranceTel +33 37 274 6760Email claire.juras@univ-lorraine.frAbstract: Surgery is the frontline treatment for a large number of cancers. The objective of these excisional surgeries is the complete removal of the primary tumor with sufficient safety margins. Removal of the entire tumor is essential to improve the chances of a full recovery. To help surgeons achieve this objective, near-infrared fluorescence-guided surgical techniques are of great interest. The concomitant use of fluorescence and indocyanine green (ICG) has proved effective in the identification and characterization of tumors. Moreover, ICG is authorized by the Food and Drug Administration and the European Medicines Agency and is therefore the subject of a large number of studies. ICG is one of the most commonly used fluorophores in near-infrared fluorescence-guided techniques. However, it also has some disadvantages, such as limited photostability, a moderate fluorescence quantum yield, a high plasma protein binding rate, and undesired aggregation in aqueous solution. In addition, ICG does not specifically target tumor cells. One way to exploit the capabilities of ICG while offsetting these drawbacks is to develop high-performance near-infrared nanocomplexes formulated with ICG (with high selectivity for tumors, high tumor-to-background ratios, and minimal toxicity). In this review article, we focus on recent developments in ICG complexation strategies to improve near-infrared fluorescence-guided tumor surgery. We describe targeted and nontargeted ICG nanoparticle models and ICG complexation with targeting agents.Keywords: near-infrared fluorescence-guided surgery, indocyanine green, nanoparticle, targeted nanoparticle, ICG complexation |
format |
article |
author |
Egloff-Juras C Bezdetnaya L Dolivet G Lassalle HP |
author_facet |
Egloff-Juras C Bezdetnaya L Dolivet G Lassalle HP |
author_sort |
Egloff-Juras C |
title |
NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green |
title_short |
NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green |
title_full |
NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green |
title_fullStr |
NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green |
title_full_unstemmed |
NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green |
title_sort |
nir fluorescence-guided tumor surgery: new strategies for the use of indocyanine green |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/821a3d36bb0e44a999b4eed4f3ce7828 |
work_keys_str_mv |
AT egloffjurasc nirfluorescenceguidedtumorsurgerynewstrategiesfortheuseofindocyaninegreen AT bezdetnayal nirfluorescenceguidedtumorsurgerynewstrategiesfortheuseofindocyaninegreen AT dolivetg nirfluorescenceguidedtumorsurgerynewstrategiesfortheuseofindocyaninegreen AT lassallehp nirfluorescenceguidedtumorsurgerynewstrategiesfortheuseofindocyaninegreen |
_version_ |
1718401130753425408 |